MarketsMOJO Upgrades TCM Ltd Rating to Sell Amid Mixed Technical and Financial Signals

Quality Assessment: Weak Fundamentals Persist

Despite the upgrade in rating, TCM Ltd’s fundamental quality remains under pressure. The company reported flat financial performance in the third quarter of FY25-26, with net sales declining by 7.93% to ₹5.69 crores. Operating losses continue to weigh heavily on the balance sheet, resulting in a negative Return on Capital Employed (ROCE), signalling inefficient capital utilisation.

Moreover, the company’s debt servicing capability is weak, with a Debt to EBITDA ratio of -1.00 times, indicating that earnings before interest, tax, depreciation and amortisation are insufficient to cover debt obligations. This financial strain is a key reason why TCM Ltd’s long-term fundamental strength remains classified as weak, limiting its appeal to value-focused investors.

Valuation: Risky and Below Par Compared to Benchmarks

From a valuation perspective, TCM Ltd is trading at levels considered risky relative to its historical averages. The stock’s current price of ₹41.05 is significantly below its 52-week high of ₹81.00, reflecting a steep correction. Over the past year, the stock has generated a negative return of 2.96%, underperforming the broader BSE500 index and the Sensex, which posted positive returns of 2.27% and 11.40% respectively over comparable periods.

Longer-term returns also paint a challenging picture. Over the last five years, TCM Ltd’s stock has declined by 8.78%, while the Sensex surged nearly 50%. Over a decade, the divergence is even starker, with TCM Ltd down 49.76% against a Sensex gain of 205.90%. This persistent underperformance underscores the stock’s valuation risk and the need for cautious investor consideration.

Financial Trend: Flat to Negative with Limited Growth Prospects

TCM Ltd’s recent quarterly results reveal a flat to negative financial trend. The company’s net sales contracted by 7.93% in Q3 FY25-26, and operating losses persisted. Although profits have risen by 95.3% over the past year, this improvement is from a low base and has not translated into positive returns for shareholders.

The company’s inability to generate consistent earnings growth and its weak debt coverage ratio highlight ongoing financial challenges. These factors contribute to the company’s low Mojo Score of 33.0 and a Mojo Grade of Sell, reflecting a cautious stance despite the recent upgrade from Strong Sell.

Technical Analysis: Mildly Bullish Signals Drive Upgrade

The primary catalyst for the upgrade in TCM Ltd’s investment rating is an improvement in technical indicators. The technical trend has shifted from sideways to mildly bullish, signalling a potential stabilisation or modest recovery in the stock price.

Key technical signals include a mildly bullish daily moving average and a bullish weekly Relative Strength Index (RSI). The monthly MACD is also bullish, although weekly MACD remains bearish, indicating mixed momentum across timeframes. Conversely, Bollinger Bands remain bearish on both weekly and monthly charts, suggesting volatility and downward pressure persist.

Other indicators such as the KST (Know Sure Thing) oscillator show a bullish monthly trend but bearish weekly readings, while Dow Theory signals no clear weekly trend and a mildly bearish monthly trend. Overall, these mixed signals have led to a cautious upgrade, reflecting technical improvement without full confirmation of a sustained uptrend.

Stock Price and Market Context

On 17 March 2026, TCM Ltd closed at ₹41.05, down 0.63% from the previous close of ₹41.31. The stock traded within a range of ₹41.05 to ₹41.99 during the day. Its 52-week low stands at ₹35.00, indicating some support near current levels, but the wide gap from the 52-week high of ₹81.00 highlights significant volatility and investor uncertainty.

Comparing returns with the Sensex reveals TCM Ltd’s underperformance across multiple time horizons. Over one week, the stock declined 2.33% versus the Sensex’s 2.66% fall, and over one month, it dropped 18.47% compared to the Sensex’s 9.34% decline. Year-to-date, the stock is down 36.00%, far exceeding the Sensex’s 11.40% loss, underscoring the stock’s heightened risk profile.

Shareholding and Sectoral Context

TCM Ltd operates within the pesticides and agrochemicals industry, a segment of the broader commodity chemicals sector. The company is classified as a micro-cap, which typically entails higher volatility and risk compared to larger peers.

Promoters remain the majority shareholders, which can be a double-edged sword: while promoter control can ensure strategic continuity, it may also limit liquidity and influence governance dynamics. Investors should weigh these factors alongside the company’s financial and technical profile.

Conclusion: Upgrade Reflects Technical Optimism Amid Fundamental Challenges

The upgrade of TCM Ltd’s investment rating from Strong Sell to Sell is primarily driven by improved technical indicators signalling a mildly bullish trend. However, the company’s weak financial fundamentals, including operating losses, negative ROCE, and poor debt servicing ability, continue to weigh heavily on its investment appeal.

Valuation risks remain elevated given the stock’s underperformance relative to benchmarks and its trading near 52-week lows. Investors should approach TCM Ltd with caution, recognising that the upgrade reflects a technical stabilisation rather than a fundamental turnaround.

For those considering exposure to the commodity chemicals sector, it may be prudent to explore alternative opportunities with stronger financial health and more favourable valuation and technical profiles.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →